1.Diagnosis and treatment for local recurrence and metastasis of patients after radical prostatectomy
China Oncology 2001;0(03):-
The incidence of biochemical recurrence after radical prostatectomy varies significantly and depends on numerous well-known prognostic factors. It likely occurs in at least 30%~40% of patients who were diagnosed as localized disease and received radical prostatectomy. Because the clinical significance of biochemical recurrence is often unclear and other predictive factors relative to the recurrence are uncertain, it is difficult to select the best treatment for the patients who might relapse in the future. This review examines some of the issues associated with biological recurrence and attempts to shed some light on this common but controversial clinical scenario. Some treatment strategies were discussed in this article including salvage radiotherapy after radical prostatectomy, watchful waiting, and hormonal therapy.
2.Analyses of clinical results of treatment with gemcitabine and cisplatin for advanced hormone independent prostate cancer
Zike QIN ; Guangwei YANG ; Fangjian ZHOU
China Oncology 2001;0(05):-
Purpose:The aim of this study was to evaluate the clinical efficacy and toxicity of treatment with gemcitabine and cisplatin for hormone independent prostate cancer.Methods:18 cases of advanced hormone independent prostate cancers who received castration and antiandrogen medicines were confirmed to have multiple bone metastatic carcinomas by emission computed tomography(ECT), and hepatic , adrenal and intracranial metastasis were found respectively each in 1 patient, and the value of PSA(prostatic special antigen) had on ascending trend in all patients. Gemcitabine 1000 mg/m~(2) +NS 100 ml was administered by intravenous drip on days 1,8 and cisplatin 100 mg/m~(2) +NS 500 ml was administered by intravenous drip on day 1 or cisplatin 30 mg/m~(2) +NS 250 ml was administered by intravenous drip on days 1 to 5 in each 28-day cycle.Results:Levels of PSA descent to normal titer(
3.Diagnosis and treatment of the urinary hemangioma(report of 20 cases)
Zike QIN ; Fangjian ZHOU ; Hua MEI
Chinese Journal of Urology 2000;0(01):-
Objective To explore the diagnostic and therapeutic methods for hemangioma in different parts of the urinary system. Methods Twenty patients with urinary hemangiomas were enrolled in this study.Of them 5 cases had hemangiomas in the kidney,2 in the ureter,10 in the bladder and 4 in urethra.Three cases (15%) had multiple hemangiomas in different parts of the body,of whom 1 case had hemangiomas concomitantly in the bladder and urethra,1 case in the bladder and neck,and 1 case in the urethra and perineum.Modalities of diagnosis before operation included B ultrasound,CT,IVU,endoscopy,et al.Surgical operations were the major treatment(95%),and only 1 patient with urethral hemangioma underwent lasar therapy. Results The pre-operation confirmed diagnosis was 0、1、9 and 4 cases for hemangiomas in kidney,ureter,bladder and urethra,respectively.For pathologic classification 13 cases were of cavernous hemangiomas,6 of capillary and 1 of racemose.With follow-up of 9 months to 16 years,recurrent bladder hemangioma was found in one patient. Conclusions The diagnoses of urinary hemangiomas mainly rely on endoscopy,but for the diagnosis of parenchyma or surface hemangioma of kidney conventional imaging examination is essential.Surgical operations were the major treatment for urinary hemangiomas,but different modalities of treatment are needed for different sites and nature of hemangiomas.
4.The effects of partial prostatic capsula sparing surgery on intestinal orthotopic neobladder
Fangjian ZHOU ; Zike QIN ; Zhigang WU
Chinese Journal of Urology 2001;0(07):-
Objective To investigate the effects of partial prostatic capsula and surrounding striated sphincter sparing surgery on the function of intestinal orthotopic neobladder. Methods Total cystectomy and orthotopic intestinal neobladder was performed in 23 male patients with invasive bladder cancer. The patients were divided into classical cystectomy group (n=10) and modified cystectomy group (n=13).In the classical group the prostate was removed completely and the residual urethra was anastomosed with the neobladder using interrupted suture.In the modified group transurethral resection of the prostate preceded the cystectomy,and the prostatic capsula below the verumontanum with its surrounding striated urethral sphincter was retained.The neobladder was anastomosed with the residual capsula using continuous suture.The function of the neobladder in the 2 groups was evaluated and compared. Results The pathological classification of the 23 patients was as follows:T 2aN 0M 0,13 cases;T 2bN 0M 0,6;T 1N 0M 0,1;T 3aN 0M 0,1;T 3bN 1M 0,1;T 4aN 0M 0,1.The patients were followed up for 3 to 40 months(mean,15.7 months).In modified group,11 patients survived disease-free and 2 survived with metastasis.All the 13 patients voided well with residual volume of 0 to 70 ml.Complete urinary continence was achieved in 12 patients and the remaining one had nocturnal incontinence.In classical group,10 patients survived disease-free;of them 7 voided well with residual volume of 10 to 100 ml and the other 3 needed intermittent catheterization because of their residual urine being up to 100 to 250 ml.Complete continence was achieved in 7 patients and the other 3 were incontinent(1 with incontinence day and night,2 with nocturnal incontinence). Conclusions Partial prostatic capsula and its surrounding striated sphincter sparing surgery can improve the continence and voiding of the orthotopic neobladder.$$$$
5.Use of posterior or anterior renal lip incision for partial nephrectomy in the treatment of renal hilum endophytic renal cell carcinoma
Zhiling ZHANG ; Yonghong LI ; Pei DONG ; Zhuowei LIU ; Fangjian ZHOU
Chinese Journal of Urology 2015;36(3):172-174
Objective To introduce our experience of performing posterior or anterior renal lip incision for partial nephrectomy in the treatment of renal hilum endophytic renal cell carcinoma.Methods From Jan.2010 to Jan.2014,five female patients with renal hilum tumors were treated in our institute.The median age was 54 (51-72) years.The median tumor diameter was 4.0 (2.8-4.8) cm.The median preoperative creatinine was 53.9 (52.6-75.4) μmol/L.One of them was solitary kidney with absolute indication; three cases had basic disease with relative indication; one was with selective indication.The patients were put in supine or lateral position.After general anesthesia,we preformed partial nephrectomy by cutting posterior renal lip in 3 cases and the anterior lip in 2 cases.We clamped the renal artery,opened the renal posterior or anterior lip,then dissected the tumor beside the pseudo-capsule.After removing the tumor,we used 3-0 absorption suture to control bleeding and repair the opened collecting system.Finally,we used 2-0 absorption suture to close the renal defect.Results The median operation time was 195 (155-215) min; the median renal warm ischemia time was 35 (15-70) min; the median postoperative hospital stay was 8 (7-9) d.There was no secondary bleeding and urine leakage happened.The pathological results showed that 3 cases with clear cell carcinoma,1 with papillary carcinoma and 1 with renal medullary interstitial cell tumor.All patients showed normal kidney shape.The median postoperative creatinine was 63.0 (59.4-75.4) μmol/L.After a median follow up of 24.2 mon,all patients survive without tumor recurrence.Conclusions The short-term result of posterior or anterior renal lip incision partial nephrectomy in treating endophytic renal hilum endophytic renal cell carcinoma is safe and feasible.
6.The clinical diagnosis, treatment and prognostic analysis of renal secondary tumor
Yingming XIAO ; Dong CHEN ; Fangjian ZHOU ; Hong LIAO
Chinese Journal of Urology 2016;37(5):331-334
Objective To investigate the clinical features,diagnosis,treatment and prognosis of the renal secondary tumor.Methods From January 2000 to January 2014,the data from 31 patients,including 23 male patients and 8 female patients,with renal secondary tumors were analyzed retrospectively.Their mean age was 56 years old (ranging from 38 to 75 years old).The 31 renal secondary tumors rooted in lung cancer(n =14),lymphoma(n =5),colorectal cancer and gastric cancer(n =3),breast cancer(n =2),esophageal cancer(n =1),thyroid cancer (n =1),cervical cancer (n =1) and bladder cancer (n =1),respectively.There were 22 patients (71.0%) of renal metastasis accompany with other organs or lymph node metastasis.9 cases (29%) suffered with independent renal metastasis and 21 cases (67.7%) suffered with unilateral renal metastasis.5 cases(16.1%) were diagnosed as primary tumor with the renal metastasis at the same time,and the remaining 26 cases were found renal metastasis within 9 to 72 months after primary tumor (mean 30 months).There were only 5 patients (16.1%) with symptom.Ultrasound showed low echo range in 20 cases (65.6%) or uneven echo in 11 cases (34.4%).CT showed equal density (77.4%) in 24 cases or slightly low density shadow (22.6%) in 7 cases,most of which were endogenous,mild enhancement.10 cases (32.3%) were bilateral renal metastasis,unilateral renal multiple metastases was found in 6 cases (19.4%),and single metastasis was noticed in 15 cases (48.4%).The average diameter of the renal metastasis was 2.7 cm (ranging from 0.9 to 6.8 cm).Except 4 cases gave up the treatment,the remaining 27 cases were accepted comprehensive therapy about the primary tumor.the 9 patients with renal metastasis only were treated with chemotherapy or targeted therapy for the advanced primary tumor.Among the 9 patients,6 cases were undergone NSS or radical nephrectomy (RN) treatment.Results In 9 cases with only renal metastasis,6 cases,treated by surgery,recovered well.Postoperative pathological and immunohistochemical results confirmed the renal metastasis.Up to January 2015,the follow-up duration ranged from 2 months to 60 months [mean (22.6 ± 18.4) months].The survival time ranged from 1 month to 51 months [mean (13.2 ± 13.2) months].Among 22 cases with multiple metastasis,4 cases gave up treatment,whose average survival time was (2.0 ± 1.4) months.However,the average survival time in remaining 18 cases was (11.1 ± 4.7) months (P < 0.05).In 9 cases with independent renal metastasis,the average survival time in 6 cases,accepted the procedure,was (26.2 ± 18.6) months.While,the average survival time in remaining 3 non-surgical cases,was (10.3 ± 4.0) months (P < 0.05).Conclusions Renal secondary tumor was rare in clinic.Most cases have isolated lesion.Renal secondary tumor was advanced manifestation of the primary tumor,which could prolong the survival time according to the comprehensive treatment for the primary tumor.Surgical resection of the lesion before the comprehensive treatment could be chosen in the independent renal metastasis.
7.Clinical comparison of patients with benign urachal masses versus urachal carcinomas
Bi XING ; Wu ZHIMING ; Han HUI ; Zhou FANGJIAN
Chinese Journal of Cancer 2017;36(1):50-52
The clinical features of 17 patients with benign urachal masses and 30 patients with urachal carcinoma treated at Sun Yat-sen University Cancer Center were analyzed retrospectively.Univariate analysis indicated that seven parameters differed significantly between the two groups.Binary logistic regression analyses showed that the rate of gross hematuria was significantly higher (P =0.042,Exp[B] =7.889) and the rate of fatty infiltration of the Retzius space was significantly lower (P =0.006,Exp[B] =0.028) in patients with urachal carcinoma than in those with benign urachal masses.Gross hematuria and fatty infiltration of the Retzius space may be indications of malignant and benign urachal masses,respectively.
8.Analysis of clinical and pathological feature of testicular diffuse large B cell lymphoma(a report of 21 cases)
Yingkun CHEN ; Dingzuan ZHANG ; Zike QIN ; Fangjian ZHOU ; Weilie HU ; Hui HAN ; Zhuowei LIU ; Yunlin YE
China Oncology 2009;19(8):619-624
Background and purpose: The clinical and pathological characteristics and treatment strategy for the patients with testicular diffuse large B cell lymphoma still need to be further studied. This study was done to evaluate the diagnosis and strategy for the disease by retrospective analysis of 21 patients with testicular diffuse large B cell lymphoma. Methods: 21 patients with pathologically proved as diffuse large B cell lymphoma after surgery in the Sun Yat-sen University Cancer Center and The Guangzhou General Hospital of PLA from September 2002 to April 2009 were accrued. There were 3 in stage Ⅰ_E , 4 in stage Ⅱ_E , 5 in stage Ⅲ_E and 9 in stage Ⅳ according to Ann Arbor stage standard. All patients received adjuvant chemotherapy with CHOP regimen initially after operation. Radiotherapy or other salvage chemotherapy regimen was given after failure of the initial treatment. The follow-up information was collected for to all of the patients. Results: Follow-up time ranged from 10 to 83 months. After completion of first-line chemotherapy(CHOP), overall response rate was 72.2%(13/18)with complete remission (CR) rate of 33.3%(6/18)and partial response rate(PR) of 38.9%(7/18). 3 patients in stage Ⅰ_E survived free from disease until now. Tumor relapsed and refractory eases were observed in 10 patients, and they all showed little response to chemotherapy with a response rate of 30.0%(3/10). Among the 21 patients, 11(52.3%) cases died of the disease with a median survival time of 28 months. Of these 21 patients, 7 patients were CD10(+), 5 patients overexpressed bel-6, 12 patients were bcl-2(+), and 15 patients overexpressed MUM1.Overexpressed bcl-2 and MUM1 indicated bad prognosis. Conclusion: Most of the testieular diffuse large B cell lymphoma patients were non-GCB. And they were sensitive to CHOP chemotherapy. The results suggested that all patients should receive chemotherapy after surgery. It was curable in the early stage. However,the options of treatment method for the patients with relapsed and refractory cases are limited and need to be further explored.
9.Clinicopathologic and prognostic analysis of papillary renal cell carcinoma
Zhiling ZHANG ; Yun CAO ; Zaishang LI ; Lijuan JIANG ; Yonghong LI ; Fangjian ZHOU
Chinese Journal of Urology 2016;37(5):328-330
Objective The aim of this study is to summarize the clinicopathologic characters and factors associated with prognosis of papillary renal cell carcinoma.Methods We treated 72 papillary renal cell carcinoma by surgery from August 2001 to February 2013,which account for 7.2% of all renal cancer patients (72/1005 cases).There were 60 male and 12 female patients included in this study,with a median age of 50 (ranging from 21-75).The median tumor diameter was 5.8cm (ranging from 4 to 8cm).Fifth-two patients were asymptomatic,14 patients presented with hematuria and 6 presented with backache.In the 72 patients,63 received (87.5%) open surgery and 9 cases (12.5%) underwent laparoscopic surgery.Fortyeight patients (66.7%) were treated with radical nephrectomy and 24 patients (33.3%) were treated with partial nephrectomy.In the current study,we summarized the clinical and pathological records and follow-up data.Cox regression analysis were performed to identify the independent predictors for cancer specific survival.Results Local lymph nodes were involved in 16 cases and distal metastasis was found in 2 cases.There were 11 cases (15.3%) of type Ⅰ papillary renal cell carcinoma and 61 cases (84.7%)of type Ⅱ.All type Ⅰ cases were determined as Fuhrman grade Ⅰ and all type Ⅱ tumor were determined as Fuhrman grade Ⅱ-Ⅳ,including grade Ⅱ in 36 cases,grade Ⅲ in 15 cases and grade Ⅳ in 30 cases.With a median follow-up duration of 35 months (ranging from 7 to 146 months),10 patients died due to renal cancer,1 died due to heart failure and the rest 61 was alive.The cancer specific survival at five years for the whole group was 78.6% (100.0% in type Ⅰ and 75.5% in type Ⅱ).The 5 year cancer specific survival rate for patients with Fuhrman grade Ⅰ-Ⅳ was 100.0%,83.5%,78.8% and 31.3%,respectively.Cox regression analysis revealed that tumor diameter (hazard ratio 1.141,P =0.019) and Fuhrman grade (hazard ratio 3.034,P =0.004) were independent prognostic factors for cancer specific survival.Conclusions Type Ⅱ papillary renal cell carcinoma has more aggressive characters and poorer prognosis compared with type Ⅰ.Tumor diameter and Fuhrman grade were independent prognostic factors for cancer specific survival.
10.Feasibility of QOL score in functional assessment of orthotopic neobladder after radical cystectomy
Hui HAN ; Fangjian ZHOU ; Bin WANG ; Yonghong LI ; Zike QIN ; Zhuowei LIU ; Xiaofeng CHEN
Chinese Journal of Urology 2008;29(6):411-414
Objective To estimate the feasibility of QOL score in functional assessment of or-thotopic neobladder after radical cystectomy. Methods Questionnaire survey,QOL score sheet and urodynamic examination were done in 22 patients with orthotopic neobladder.Investigations were fo-CUS on the micturition interval during daytime and nighttime.Micturition time,degree of incontinence and their relationship with QOI.scores and urodynamic parameters wete also analyzed. ResuIts There were 3,6,7,1,2,3 and 0 cases which QOI.score were 0 to 6 accordingly.In the dav time,2 patients complained a light incontinence while 1 patient of moderate incontinence.In the nighttime.3 patients had the complaint of moderate incontinence while 4 patients of light incontinence.The average daytime mlcturltlon interval was 136 min(45-210 rain).The average maximum urinary flow rate,maximal urethral closure pressure and postvoid residual were 12.9 ml/s(2.7-22.1 ml/s),69.3 cm H2O(33-114 em H20)and 91.8 ml(5-300 m1)respectively.QOL scores had D.sitive correlation with the degree of incontinence during daytime and nighttime(daytime:r-0.510,P=0.015,night time:r=0.911,P<0.001).The QOL scores had negative correlation with daytime micturition inter-val(r=-0.749,P<0.001).The factors which influenced the QOL scores included the maximaI ure-thral closure pressure,postvoid residual and the maximum urinary flow rate. Conclusions QOL score reflects the patients"continent ability,subjective feelings on quality of life.It is correlated with the common urodynamic parameters.QOI.score might be used as a new index to estimate the function of orthotopic neobladder.